Transition Metal Ions Promote the Bioavailability of Hydrophobic Therapeutics: Cu and Zn Interactions with RNA Polymerase I Inhibitor CX5461
April 25, 2018 Chemistry: a European Journal
Prosser K.E., Leung, A.W.Y., Harrypersad, S., Lewis A.R., Bally, M.B., and Walsby, C.J.

Copper (II) Complexes of Bidentate Ligands Exhibit Potent Anti-Cancer Activity Regardless of Platinum Sensitivity Status
July 21, 2017 Investigational New Drugs
Wehbe, M., Lo, C., Leung, A.W.Y., Dragowska, W.H., Ryan, G.M., and Bally, M.B.

A Perspective – Can Copper Complexes be Developed as a Novel Class of Therapeutics?
July 4, 2017 Dalton Transactions
Wehbe, M., Leung, A., Abrams, M.J., Orvig, C., and Bally, M.B.

Development and Optimization of an Injectable Formulation of Copper Diethyldithiocarbamate, an Active Anticancer Agent
May 31, 2017 International Journal of Nanomedicine
Wehbe, M., Anantha, M., Shi, M., Leung, A.W.Y., Dragowska, W.H., Sanche, L, and Bally, M.B.

Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development
April 7, 2016 PLOS ONE
Wehbe, M., Anantha, M., Backstrom, I., Leung, A., Chen, K., Malhotra, A., Edwards, K., and Bally, M.B.